Cencora (NYSE:COR) Shares Gap Down - What's Next?

Key Points

• Cencora shares gapped down 3.8%, opening at $319.59 after closing at $333.87, as investors remained concerned about revenue-growth headwinds.
• Management lowered fiscal 2026 revenue-growth guidance to 4%–6%, citing lower wholesale acquisition prices, IRA-related reductions, slower GLP-1 growth, customer losses and faster brand conversions.
• Despite the caution, quarterly EPS and revenue exceeded estimates, while analysts maintain a generally favorable “Moderate Buy” consensus and the company supports shareholders through a $2 billion buyback and $0.60 quarterly dividend.

Cencora, Inc. (NYSE:COR - Get Free Report)'s share price gapped down prior to trading on Wednesday . The stock had previously closed at $333.87, but opened at $319.59. Cencora shares last traded at $321.3230, with a volume of 178,179 shares changing hands.

Key Headlines Impacting Cencora

Here are the key news stories impacting Cencora this week:

• Positive Sentiment: Wells Fargo raised its price target on Cencora from $331 to $395 and maintained an “overweight” rating, implying meaningful potential upside from recent trading levels. Benzinga report
• Positive Sentiment: Brokerage coverage remains generally favorable, with Cencora receiving an average “Moderate Buy” rating and a median analyst target of $339. These ratings may help limit downside if revenue concerns stabilize. Average brokerage rating
• Positive Sentiment: Institutional activity was mixed but included substantial purchases, led by JPMorgan Chase adding nearly 5.9 million shares. Recent insider activity was also net positive, with three purchases versus one sale over six months, although these transactions are not necessarily tied to current fundamentals.
• Neutral Sentiment: Recent earnings-call coverage continues to examine Cencora’s quarterly performance, customer trends and outlook, but the available reports do not identify a new catalyst that would materially change the investment case. Earnings call analysis
• Negative Sentiment: Investors remain cautious after Cencora reduced its fiscal 2026 revenue-growth outlook to 4%–6%. Management cited lower wholesale acquisition prices and IRA-related reductions, faster brand conversions at a major mail-order customer, slower GLP-1 growth and customer losses.
• Negative Sentiment: Analysts have previously lowered several price targets following the outlook reset, reinforcing concerns that top-line pressure could persist even though adjusted earnings expectations, cash flow and share-repurchase support remain comparatively strong. Cencora share-movement analysis

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. JPMorgan Chase & Co. boosted their target price on shares of Cencora from $382.00 to $390.00 and gave the stock an "overweight" rating in a research note on Friday, August 7th. Morgan Stanley raised their price target on shares of Cencora from $342.00 to $346.00 and gave the company an "overweight" rating in a report on Friday. Evercore restated an "outperform" rating and issued a $350.00 price objective on shares of Cencora in a research report on Thursday, August 6th. Barclays decreased their price objective on Cencora from $425.00 to $350.00 and set an "overweight" rating on the stock in a research report on Wednesday, June 10th. Finally, Wells Fargo & Company boosted their target price on Cencora from $331.00 to $395.00 and gave the stock an "overweight" rating in a research report on Tuesday. Thirteen equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat.com, Cencora has an average rating of "Moderate Buy" and an average price target of $374.25.

Cencora Trading Down 3.8%

The company has a debt-to-equity ratio of 3.53, a current ratio of 0.93 and a quick ratio of 0.58. The business has a 50 day moving average of $296.42 and a 200 day moving average of $313.81. The firm has a market capitalization of $62.48 billion, a price-to-earnings ratio of 23.86, a PEG ratio of 1.87 and a beta of 0.57.

Cencora (NYSE:COR - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.35 by $0.13. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The firm had revenue of $84.75 billion during the quarter, compared to analysts' expectations of $84.31 billion. During the same quarter in the previous year, the company earned $4.00 earnings per share. The business's revenue for the quarter was up 5.1% on a year-over-year basis. As a group, research analysts predict that Cencora, Inc. will post 17.84 earnings per share for the current fiscal year.

Cencora Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be given a $0.60 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. Cencora's dividend payout ratio (DPR) is 17.83%.

Cencora declared that its board has approved a share buyback program on Thursday, May 21st that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to repurchase up to 3.9% of its stock through open market purchases. Stock buyback programs are often an indication that the company's board of directors believes its stock is undervalued.

Insider Buying and Selling at Cencora

In related news, Director Lauren M. Tyler bought 550 shares of the stock in a transaction that occurred on Monday, June 22nd. The shares were acquired at an average price of $270.23 per share, with a total value of $148,626.50. Following the completion of the transaction, the director owned 4,359 shares in the company, valued at $1,177,932.57. The trade was a 14.44% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.38% of the stock is owned by insiders.

Institutional Trading of Cencora

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Kemnay Advisory Services Inc. bought a new stake in shares of Cencora in the 4th quarter valued at about $25,000. Oakworth Capital Inc. acquired a new position in shares of Cencora during the 4th quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new position in shares of Cencora during the 4th quarter worth approximately $27,000. Archer Investment Corp lifted its holdings in Cencora by 134.3% during the 4th quarter. Archer Investment Corp now owns 82 shares of the company's stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. Finally, Motiv8 Investments LLC acquired a new stake in Cencora during the 4th quarter valued at $29,000. 97.52% of the stock is owned by institutional investors.

About Cencora

Cencora NYSE: COR is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company's core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source